AAAAAA
Results:
1-7
|
Results: 7
Authors:
Weiel, JE
Lenhard, JM
Citation: Je. Weiel et Jm. Lenhard, Chapter 13. In vitro and in vivo approaches to studying antiretroviral therapy (ART)-induced metabolic complications, ANNU REP M, 36, 2001, pp. 129-137
Authors:
Lenhard, JM
Croom, DK
Weiel, JE
Winegar, DA
Citation: Jm. Lenhard et al., HIV protease inhibitors stimulate hepatic triglyceride synthesis, ART THROM V, 20(12), 2000, pp. 2625-2629
Authors:
Weiel, JE
Lenhard, JM
Citation: Je. Weiel et Jm. Lenhard, Bone mineral loss in HIV-positive patients receiving antiretroviral therapy, AIDS, 14(14), 2000, pp. 2218-2219
Authors:
Lenhard, JM
Furfine, ES
Jain, RG
Ittoop, O
Orband-Miller, LA
Blanchard, SG
Paulik, MA
Weiel, JE
Citation: Jm. Lenhard et al., HIV protease inhibitors block adipogenesis and increase lipolysis in vitro, ANTIVIR RES, 47(2), 2000, pp. 121-129
Authors:
Lenhard, JM
Croom, DK
Weiel, JE
Spaltenstein, A
Reynolds, DJ
Furfine, ES
Citation: Jm. Lenhard et al., Dietary fat alters HIV protease inhibitor-induced metabolic changes in mice, J NUTR, 130(9), 2000, pp. 2361-2366
Authors:
Lenhard, JM
Weiel, JE
Paulik, MA
Furfine, ES
Citation: Jm. Lenhard et al., Stimulation of vitamin A(1) acid signaling by the HIV protease inhibitor indinavir, BIOCH PHARM, 59(9), 2000, pp. 1063-1068
Authors:
Lenhard, JM
Lancaster, ME
Paulik, MA
Weiel, JE
Binz, JG
Sundseth, SS
Gaskill, BA
Lightfoot, RM
Brown, HR
Citation: Jm. Lenhard et al., The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction, DIABETOLOG, 42(5), 1999, pp. 545-554
Risultati:
1-7
|